#BerGenBio to Present Top Line Translational P2 Data- Bemcentinib in Combination With Keytruda® in NSCLC Patients At Next Gen Immuno-Oncology Congress | BioSpace “abstract has been accepted for oral virtual presentation Next Gen 25-26 June 2020 $BRRGF $MRK https://t.co/Czn732LUZy